Financials • Specialty Insurers
$1.12 ▼ -0.03
(-2.61%)
MKT CAP: $95.4M • VOL: 269.1K
52W L $1 52W H $3
ROARABLE / RQD
E • 22/100
PIOTROSKI
3 / 9
RDZN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $55.0M | $44.3M | $46.7M |
| YoY Revenue Growth % | +24.2% | -5.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$14.0M | -$60.8M | -$77.7M |
| Operating Margin % | -25.4% | -80.0% | -80.0% |
| Net Income (GAAP) | -$22.5M | -$72.9M | -$99.7M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$20.3M | -$18.1M | -$19.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$20.3M | -$18.1M | -$19.2M |
| FCF Margin % | -36.8% | -41.0% | -41.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $5.1M | $5.8M | — |
| Total Debt (Short + Long Term) | $4.8M | $117.1K | — |
| Total Stockholders' Equity | -$26.6M | -$29.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR RDZN.